August 23, 2021
August 23, 2021 – Pfizer and BioNTech have received full FDA approval for their vaccine to prevent COVID-19 in individuals who are at least 16 years old. The vaccine
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
GlobalReach Health
August 23, 2021
August 23, 2021 – KorsuvaTM (difelikefalin) has been FDA approved to treat moderate-to-severe pruritus (itching) associated with chronic kidney disease in adults
August 20, 2021
August 20, 2021 – The U.S. FDA has approved Opdivo® (nivolumab) as an adjuvant treatment for patients who have urothelial carcinoma and are at high risk of
August 18, 2021
August 18, 2021 – Jardiance® (empagliflozin) 10mg, manufactured by Boehringer Ingelheim and Eli Lilly, is now U.S. FDA approved to reduce the risk of cardiovascular death plus hospitalization
August 17, 2021
August 17, 2021 – The U.S. FDA has approved a new indication for Jemperli® (dostarlimab-gxly), manufactured by GlaxoSmithKline. The drug is now
August 16, 2021
August 16, 2021 – Genentech, the manufacturer of Actemra® (tocilizumab), has announced a global shortage of the drug's intravenous (IV) form due to high demand
August 16, 2021
August 16, 2021 – Pfizer has recalled an additional four lots of Chantix® (varenicline) after identifying a nitrosamine impurity, N-nitroso-varenicline, above the manufacturer’s established acceptable
August 16, 2021
August 16, 2021 – The U.S. FDA has approved Merck’s WeliregTM (belzutifan), the first hypoxia-inducible
factor-2 alpha (HIF-2α) inhibitor to become